DG Capital Management (Massachusetts)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
BIT
BFA
DG Capital Management (Massachusetts)'s GILD Position: Q3 2016 in Review
DG Capital Management (Massachusetts) sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 6,391 shares — an estimated $533K sold.
DG Capital Management (Massachusetts) first reported a position in GILD in Q2 2013 and held it in 13 quarters. The position peaked at $6.85M in Q4 2013. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.
- DG Capital Management (Massachusetts) reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
- DG Capital Management (Massachusetts) sold 6,391 Gilead Sciences shares in Q3 2016, an estimated $533K.
- DG Capital Management (Massachusetts) first reported a position in Gilead Sciences in Q2 2013 and held it in 13 quarters.
- DG Capital Management (Massachusetts)'s Gilead Sciences position peaked at $6.85M in Q4 2013.
- 1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.
Based on DG Capital Management (Massachusetts)'s 13F filing for Q3 2016, filed 21 Oct 2016.